PTC Therapeutics (PTCT) Stock Price
$50.69 0%
to add to portfolio
AI Score
-
Alternative
7 -
Fundamental
2 -
Technical
6
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on PTC Therapeutics, AI stock picks, stock alerts and much more.
PTCT AI Stock Analysis
AI stock analysis for PTCT is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like PTC Therapeutics (PTCT) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
PTC Therapeutics (PTCT) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of PTC Therapeutics (PTCT), currently trading at $50.69, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About PTCT
-
PTC Therapeutics, Inc.
-
Symbol
PTCT
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
3.9B
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$21.62 2% |
6 |
 |
Inovio Pharmaceuticals INO |
$2.24 0.9% |
2 |
 |
Moderna MRNA |
$35.53 5.3% |
4 |
 |
Anavex Life Sciences AVXL |
$8.35 3.8% |
6 |
 |
BridgeBio Pharma BBIO |
$36.85 0.1% |
6 |
News
PTCT Alternative Data
Web Traffic
PTC Therapeutics receives an estimated 28332 monthly visitors to ptcbio.com.
-
Web Traffic
28332
-
Change from Previous Month
6.6%
-
3 Month Change
22%
-
YoY Change
22%
News Mentions
PTC Therapeutics was mentioned 1 times in the news yesterday.
-
News Mentions
1
-
Daily Change
66.7%
-
1 Month Change
0%
-
3 Month Change
50%
Reddit Mentions
PTC Therapeutics has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
Twitter Followers
PTC Therapeutics has 2,313 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.6% over the last month.
-
Twitter Followers
2313
-
Daily Change
0%
-
1 Month Change
0.6%
-
3 Month Change
1.6%
-
YoY Change
1.6%
Facebook Engagement
PTC Therapeutics has engaged 111 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
111
-
Daily Change
14.4%
-
1 Month Change
5450%
-
3 Month Change
39%
-
YoY Change
39%
Job Postings
PTC Therapeutics currenly has an estimated 43 open job postings, up by 38.7% over the last month.
-
Job Postings
43
-
Daily Change
30.3%
-
1 Month Change
38.7%
-
3 Month Change
19.4%
-
YoY Change
19.4%
LinkedIn Employees
According to LinkedIn, PTC Therapeutics has 1,144 employees, down by -0.1% over the last month.
-
LinkedIn Employees
1144
-
Daily Change
0%
-
1 Month Change
0.1%
-
3 Month Change
0.2%
-
YoY Change
0.2%
Instagram Followers
PTC Therapeutics has 3,526 Instagram Followers on its main Instagram account, up by 1.9% over the last month.
-
Instagram Followers
3526
-
Daily Change
0.2%
-
1 Month Change
1.9%
-
3 Month Change
6.7%
-
YoY Change
6.7%
Business Outlook
-
Business Outlook
51
-
Change from Previous Month
1.9%
-
3 Month Change
0%
-
YoY Change
0%
PTCT Financials
PTCT Key Metrics
-
Total Revenue
$196.8M
-
Net Income
-$106.7M
-
Earnings per Share
-$1.39
-
Free cash flow
-$22.8M
-
EBITDA
-$49.9M
-
EBITDA Ratio
-0.253555
-
Total Assets
$1.8B
PTCT 2-year Revenue & Income
PTCT 2-year Free Cash Flow
PTCT Technicals
PTCT SMA
PTCT RSI
FAQ
What's the current price of PTC Therapeutics (PTCT) Stock?
The price of an PTC Therapeutics (PTCT) share is $50.69.
What's the market cap of PTC Therapeutics?
The current market cap of PTC Therapeutics is 3.9B.
Should I buy or sell PTCT?
PTC Therapeutics shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, PTC Therapeutics is better viewed as a hold or accumulate position while waiting for further developments.
Is PTC Therapeutics a good investment?
The current analysis of PTC Therapeutics' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in PTC Therapeutics' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy PTC Therapeutics (PTCT) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for PTC Therapeutics stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to PTC Therapeutics (PTCT) that investors often compare it to?
PTC Therapeutics (PTCT) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for PTC Therapeutics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast PTC Therapeutics' stock price to be around $50.43 in 2026. Starting from the current price of $50.69, this represents a 0.5% change in price, indicating a neutral outlook for the stock.
How to buy PTC Therapeutics (PTCT) Stock?
PTC Therapeutics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy PTC Therapeutics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.